Toll Free: 1-888-928-9744

Molecular Diagnostics Market Analysis By Product (Instruments, Reagents), By Test Location (Point of Care, Self Test, Central Laboratories), By Application (Oncology, Breast Cancer, Prostate Cancer , Colorectal Cancer Pharmacogenomics, Infectious Disease, MRSA, Clostridium Difficile, Vancomycin-resistant Enterococci, Carbapenem-resistant Bacteria Testing, Flu, Respiratory Syncytial Virus (RSV), Candida, Tuberculosis and drug-resistant TB), By Technology And Segment Forecasts To 2022

Published: Nov 2, 2015 | Pages: 89 | Publisher: Grand View Research | Industry: Biotechnology | Report Format: Electronic (PDF)

The global molecular diagnostics market is expected to reach over USD 9.50 billion by 2022, according to a new report by Grand View Research Inc. Growing prevalence of chronic diseases and infections such as HPV and influenza is anticipated to be the key driver for molecular diagnostics market growth. Moreover, increasing demand for rapid and accurate diagnostic devices for early validation of such diseases is further expected to enhance usage rates during the forecast period.

Increasing adoption of sedentary lifestyle coupled with decrease in immunity levels is expected to provide the market with a largetarget patient base. Growing awareness levels pertaining to prenatal genetic testing for early detection of developmental abnormalities and defects is also anticipated to increase penetration levels. Technological advancement on the grounds of accuracy, portability, and cost-effectiveness isalso expected to serve this market as a high impact rendering driver.

Further key findings from the report suggest:

Reagents dominated the overall market with a revenue share of over50.0% in 2014 owing to, their high usage rates. Growing initiatives by researchers in this field for detection of disease related novel biomarkers for drug development purpose isa key factor attributing for the segment's large share.
Instruments on the other hand are expected to grow at constant CAGR of 6.2% from 2015 to 2022 owing to technological advancements and rising need for lab automation.
Central laboratories dominated the overall market in terms of revenue share in 2014. Presence of established healthcare infrastructure and trained manpower are key factors attributing to its large market share.
Increasing demand for user-friendly, portable, and rapid analysis devices is a key factor resulting in the lucrative growth of the point of care devices segment. The segment is estimated to grow at a CAGR of 11.8% over the forecast period.
Infectious diseases dominated the market with share of over 50.0% in 2014 owing to the presence of high usage rates of molecular testing tools such as multiplex PCR in the detection of a myriad of infectious diseases caused by virus, bacteria, and pathogens. Commonly diagnosed infectious diseases include Clostridium difficile infection,Flu, HIV-1, HIV-2 (HIV-AIDS), HSV-1, HSV-2 (meningitis and encephalitis), Hepatitis C and B, gastro intestinal diseases, and MRSA infection.
The molecular diagnostics based oncology market is likely to witness lucrative growth over the forecast period. Increasing application of molecular diagnostic devices in the validation and differentiation of various cancer subtypes and the development of companion diagnostics for cancer drugs are further expected to boostsegment growth.
In 2014, the polymerase chain reaction technology based molecular diagnostics marketaccounted forthe largest revenue share owing to, the introduction of technologically advanced product range and higher acceptance levels by researchers
North America dominated the market in terms of revenue in 2014, owing to the presence of sophisticated healthcare infrastructure, high patient awareness levels, high levels of disposable income, and high R&D activities pertaining to drug discovery and development
Asia Pacific is expected to witness significant growth of over 12% over the forecast period. Growing base of target disease population, increasing demand for rapid diagnostic techniques for prevention of epidemics, and significant economic growth are expected to provide market with potential platform for growth
Some key players of this market include Abbott Laboratories, Alere Inc., Bayer Healthcare, Becton Dickinson, bioMerieux, Bio-Rad Laboratories, Cepheid, Dako, Danaher Corporation, Hologic(Gen Probe), Johnson & Johnson, Novartis (Grifols), Qiagen N.V., Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation
Participants are constantly engaged in the introduction of technological advancements and the development of novel diagnostic products and applications in an attempt to improve marketpresence and ensure sustainability
 Table of Contents
Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research Scope & Assumptions 1.3 List of Data Sourcess Chapter 2 Executive Summary Chapter 3 Molecular Diagnostics - Industry Outlook 3.1 Introduction 3.2 Market Segmentation 3.3 Market Size and Growth Prospects 3.4 Molecular Diagnostics - Market dynamics 3.4.1 Market Driver Analysis 3.4.1.1 Growing geriatric population base 3.4.1.2 Introduction of technological advancements 3.4.1.3 Increasing demand for point of care facilities 3.4.1.4 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases 3.4.1.5 External funding for executing research and development exercises 3.4.2 Market Restraint Analysis 3.4.2.1 Presence of ambiguous regulatory framework 3.4.2.2 High prices of molecular diagnostics tests 3.5 Key Opportunities Prioritized 3.7 Molecular Diagnostics - PESTEL Analysis 3.8 Molecular Diagnostics Market - Company Market Share Analysis, 2013 3.8.1 Recommendations for market participants Chapter 4 Molecular Diagnostics Product Outlook 4.1 Molecular Diagnostics Revenue Share by Product, 2014 & 2022 4.2 Molecular Diagnostic Instruments Market 4.2.1 Molecular Diagnostic Instruments Market, 2012 - 2022 (USD Million) 4.3 Molecular Diagnostic Reagents Market 4.3.1 Molecular Diagnostic Reagents Market, 2012 - 2022 (USD Million) 4.4 Others 4.4.1 Other Molecular Diagnostic Products Market, 2012 - 2022 (USD Million) Chapter 5 Molecular Diagnostics Test Location Outlook 5.1 Molecular Diagnostics Revenue Share by Test Location, 2014 & 2022 5.2 Molecular Diagnostic Point of Care Market 5.2.1 Molecular Diagnostic Point Of Care Market, 2012 - 2022 (USD Million) 5.3 Molecular Diagnostics Self-Test or OTC Market 5.3.1 Self-Test or OTC Molecular Diagnostics Market, 2012 - 2022 (USD Million) 5.4 Molecular Diagnostic Central Laboratories Market 5.4.1 Molecular Diagnostic Central Laboratories Market, 2012 - 2022 (USD Million) Chapter 6 Molecular Diagnostics Application Outlook 6.1 Molecular Diagnostics Revenue Share by Application, 2014 & 2022 6.2 Molecular Diagnostics Based Oncology Market 6.2.1 Molecular Diagnostics Based Oncology Market, 2012 - 2022 (USD Million) 6.2.2 Molecular Diagnostics Based Breast Cancer Market, 2012 - 2022 (USD Million) 6.2.3 Molecular Diagnostics Based Prostate Cancer Market, 2012 - 2022 (USD Million) 6.2.4 Molecular Diagnostics Based Colorectal Cancer Market, 2012 - 2022 (USD Million) 6.2.5 Molecular Diagnostics Based Others Market, 2012 - 2022 (USD Million) 6.3 Molecular Diagnostics Based Pharmacogenomics Market 6.3.1 Molecular Diagnostics Based Pharmacogenomics Market, 2012 - 2022 (USD Million) 6.4 Molecular Diagnostics Based Infectious Disease Market 6.4.1 Molecular Diagnostics Based Infectious Disease Market, 2012 - 2022 (USD Million) 6.4.2 Molecular Diagnostics Based MRSA Market, 2012 - 2022 (USD Million) 6.4.3 Molecular Diagnostics Based Clostridium Difficile Market, 2012 - 2022 (USD Million) 6.4.4 Molecular Diagnostics Based Vancomycin Resistant Enterococci Market, 2012 - 2022 (USD Million) 6.4.5 Molecular Diagnostics Based Carbapenem Resistant Bacteria Testing Market, 2012 - 2022 (USD Million) 6.4.6 Molecular Diagnostics Based Flu Market, 2012 - 2022 (USD Million) 6.4.7 Molecular Diagnostics Based Respiratory Syncytial Virus Market, 2012 - 2022 (USD Million) 6.4.8 Molecular Diagnostics Based Candida Market, 2012 - 2022 (USD Million) 6.4.9 Molecular Diagnostics Based Tuberculosis and Drug Resistant TB Market, 2012 - 2022 (USD Million) 6.4.10 Molecular Diagnostics Based Meningitis Market, 2012 - 2022 (USD Million) 6.4.11 Molecular Diagnostics Based Gastro-intestinal Panel Testing Market, 2012 - 2022 (USD Million) 6.4.12 Molecular Diagnostics Based Chlamydia Market, 2012 - 2022 (USD Million) 6.4.13 Molecular Diagnostics Based Gonorrhea Market, 2012 - 2022 (USD Million) 6.4.14 Molecular Diagnostics Based HIV Market, 2012 - 2022 (USD Million) 6.4.15 Molecular Diagnostics Based Hepatitis C Market, 2012 - 2022 (USD Million) 6.4.16 Molecular Diagnostics Based Hepatitis B Market, 2012 - 2022 (USD Million) 6.4.17 Molecular Diagnostics Based Other Infectious Disease Market, 2012 - 2022 (USD Million) 6.5 Molecular Diagnostic Based Genetic Testing Market 6.5.1 Molecular Diagnostics Based Genetic Testing Market, 2012 - 2022 (USD Million) 6.5.2 Molecular Diagnostics Based Newborn Screening Market, 2012 - 2022 (USD Million) 6.5.3 Molecular Diagnostics Based Predictive and PresymptomaticTesting Market, 2012 - 2022 (USD Million) 6.5.4 Molecular Diagnostics Based Others Market, 2012 - 2022 (USD Million) 6.6 Molecular Diagnostics Based Neurological Diseases Market 6.6.1 Molecular Diagnostics Based Neurological Diseases Market, 2012 - 2022 (USD Million) 6.7 Molecular Diagnostics Based Cardiovascular Diseases Market 6.7.1 Molecular Diagnostics Based Cardiovascular Diseases Market, 2012 - 2022 (USD Million) 6.8 Molecular Diagnostics Based Food Safety Market 6.8.1 Molecular Diagnostics Based Food Safety Market, 2012 - 2022 (USD Million) 6.9 Molecular Diagnostics Based Microbiology Market 6.9.1 Molecular Diagnostics Based Microbiology Market, 2012 - 2022 (USD Million) 6.10 Molecular Diagnostics in Other Applications Market 6.10.1 Molecular Diagnostics in Other Applications, 2012 - 2022 (USD Million) Chapter 7 Molecular Diagnostics Technology Outlook 7.1 Molecular Diagnostics Revenue Share by Technology, 2014 & 2022 7.2 Molecular Diagnostics Polymerase Chain Reaction (PCR) Market 7.2.1 Molecular Diagnostics PCR Market, 2012 - 2022 (USD Million) 7.2.2 Multiplex Polymerase Chain Reaction Based Molecular Diagnostics Market, 2012 - 2022 (USD Million) 7.2.3 Other Polymerase Chain Reaction Based Molecular Diagnostics Market, 2012 - 2022 (USD Million) 7.3 Molecular Diagnostics In-situ Hybridization Market 7.3.1 Molecular Diagnostic In-situ Hybridization Market, 2012 - 2022 (USD Million) 7.4 Molecular Diagnostics Chips and Microarrays Market 7.4.1 Molecular Diagnostics Chips and Microarrays Market, 2012 - 2022 (USD Million) 7.5 Molecular Diagnostics Mass Spectrometry (MS) Market 7.5.1 Molecular Diagnostics Mass Spectrometry Market, 2012 - 2022 (USD Million) 7.6 Molecular Diagnostic Sequencing Market 7.6.1 Molecular Diagnostic Sequencing Market, 2012 - 2022 (USD Million) 7.7 Molecular Diagnostics Transcription Mediated Amplification (TMA) Market 7.7.1 Molecular Diagnostics TMA Market, 2012 - 2022 (USD Million) 7.8 Molecular Diagnostic Other Technology Segments Market 7.8.1 Molecular Diagnostic Other Technology Segments Market, 2012 - 2022 (USD Million) Chapter 8 Molecular Diagnostics Regional Outlook 8.1 Molecular Diagnostics Revenue Share by Region, 2014 & 2022 8.2 North America 8.2.1 North America Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.2.2 U.S. Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.2.3 Canada Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3 Europe 8.3.1 Europe Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3.2 UK Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3.3 Germany Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3.4 France Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3.5 Spain Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.3.6 Italy Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4.2 Japan Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4.3 China Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4.4 India Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4.5 Australia Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.4.6 New Zealand Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.5 Latin America 8.5.1 Latin America Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.5.2 Brazil Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.5.3 Mexico Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.5.4 Colombia Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.6 MEA 8.6.1 MEA Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.6.2 South Africa Molecular Diagnostic Market, 2012 - 2022 (USD Million) 8.6.3 Saudi Arabia Molecular Diagnostic Market, 2012 - 2022 (USD Million) Chapter 9 Competitive Landscape 9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Financial Performance 9.1.3 Product Benchmarking 9.1.4 Strategic Initiatives 9.2 Alere Inc. 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Product Benchmarking 9.2.4 Strategic Initiatives 9.3 Bayer Healthcare 9.3.1 Company Overview 9.3.2 Financial Performance 9.3.3 Product Benchmarking 9.3.4 Strategic Initiatives 9.4 Becton Dickinson 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Product Benchmarking 9.4.4 Strategic Initiatives 9.5 bioMerieux 9.5.1 Company Overview 9.5.2 Financial Performance 9.5.3 Product Benchmarking 9.5.4 Strategic Initiatives 9.6 Bio-Rad Laboratories ? 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Product Benchmarking 9.6.4 Strategic Initiatives 9.7 Cepheid 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Product Benchmarking 9.7.4 Strategic Initiatives 9.8 Dako 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Product Benchmarking 9.8.4 Strategic Initiatives 9.9 Danaher Corporation 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Benchmarking 9.9.4 Strategic Initiatives of Danaher Corporation 9.10 Hologic (Gen Probe) 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Product Benchmarking 9.11 Johnson & Johnson 9.11.1 Company Overview 9.11.2 Financial Performance 9.11.3 Product Benchmarking 9.11.4 Strategic Initiatives 9.12 Novartis (Grifols) 9.12.1 Company Overview 9.12.2 Financial Performance 9.12.3 Product Benchmarking 9.12.4 Strategic Initiatives 9.13 Qiagen N.V. 9.13.1 Company Overview 9.13.2 Financial Performance 9.13.3 Product Benchmarking 9.13.4 Strategic Initiatives 9.14 Roche Diagnostics 9.14.1 Company Overview 9.14.2 Financial Performance 9.14.3 Product Benchmarking 9.14.4 Strategic Initiatives 9.15 Siemens Healthcare 9.15.1 Company Overview 9.15.2 Financial Performance 9.15.3 Product Benchmarking 9.15.4 Strategic Initiatives 9.16 Sysmex Corporation 9.16.1 Company Overview 9.16.2 Financial Performance 9.16.3 Product Benchmarking 9.16.4 Strategic Initiatives
List of Tables
TABLE 1 Molecular Diagnostics - Industry summary & Critical Success Factors (CSFs) TABLE 2 Global Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 3 Global Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 4 Global Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 5 Global Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 6 Global Molecular Diagnostics Market, by Region, 2012 - 2022 (USD Million) TABLE 7 Molecular Diagnostics - Key market driver analysis TABLE 8 Molecular Diagnostics - Key market restraint analysis TABLE 9 Global Multiplex PCR Based Molecular Diagnostics Market, by Region, 2012 - 2022 (USD Million) TABLE 10 North America Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 11 North America Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 12 North America Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 13 North America Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 14 U.S. Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 15 U.S. Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 16 U.S. Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 17 U.S. Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 18 Canada Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 19 Canada Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 20 Canada Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 21 Canada Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 22 Europe Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 23 Europe Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 24 Europe Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 25 Europe Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 22 UK Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 23 UK Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 24 UK Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 25 UK Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 26 Germany Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 27 Germany Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 28 Germany Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 29 Germany Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 30 France Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 31 France Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 32 France Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 33 France Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 34 Spain Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 35 Spain Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 36 Spain Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 37 Spain Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 38 Italy Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 39 Italy Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 40 Italy Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 41 Italy Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 42 Asia Pacific Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 43 Asia Pacific Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 44 Asia Pacific Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 45 Asia Pacific Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 46 Japan Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 47 Japan Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 48 Japan Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 49 Japan Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 50 China Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 51 China Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 52 China Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 53 China Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 54 India Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 55 India Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 56 India Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 57 India Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 58 Australia Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 59 Australia Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 60 Australia Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 61 Australia Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 62 New Zealand Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 63 New Zealand Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 64 New Zealand Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 65 New Zealand Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 66 Latin America Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 67 Latin America Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 68 Latin America Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 69 Latin America Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 70 Brazil Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 71 Brazil Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 72 Brazil Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 73 Brazil Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 74 Mexico Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 75 Mexico Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 76 Mexico Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 77 Mexico Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 78 Colombia Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 79 Colombia Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 80 Colombia Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 81 Colombia Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 82 MEA Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 83 MEA Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 84 MEA Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 85 MEA Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 86 South Africa Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 87 South Africa Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 88 South Africa Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 89 South Africa Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million) TABLE 90 Saudi Arabia Molecular Diagnostics Market, by Product, 2012 - 2022 (USD Million) TABLE 91 Saudi Arabia Molecular Diagnostics Market, by Technology, 2012 - 2022 (USD Million) TABLE 92 Saudi Arabia Molecular Diagnostics Market, by Application, 2012 - 2022 (USD Million) TABLE 93 Saudi Arabia Molecular Diagnostics Market, by Test Location, 2012 - 2022 (USD Million)


List of Figures
FIG. 1 Molecular Diagnostics: Market Segmentation FIG. 2 Molecular Diagnostics Market Revenue, 2012 - 2022 (USD million) FIG. 3 Molecular Diagnostics Market Dynamics FIG. 4 Global percentage of population, by age group, 2000 and 2050 FIG. 5 General Trend of CLIA Waived Tests FIG. 6 Average selling price range of diagnostic tests, 2013 FIG. 7 Key Opportunities Prioritized FIG. 8 Molecular Diagnostics Market - Porter's Analysis FIG. 9 Molecular Diagnostics Market - PESTEL Analysis FIG. 10 Company Market Share Analysis - Molecular Diagnostics Market, 2013 FIG. 11 Recommendations for market participants FIG. 12 Molecular diagnostics revenue share by product, 2014 & 2022 FIG. 13 Molecular diagnostic instruments Market, 2012 - 2022 (USD Million) FIG. 14 Molecular diagnostic reagents Market, 2012 - 2022 (USD Million) FIG. 15 Other Molecular diagnostic Products Market, 2012 - 2022 (USD Million) FIG. 16 Molecular diagnostics revenue share by test location, 2014 & 2022 FIG. 17 Molecular diagnostic Point Of Care Market, 2012 - 2022 (USD Million) FIG. 18 Self Test or OTC Molecular Diagnostics Market, 2012 - 2022 (USD Million) FIG. 19 Molecular diagnostic central laboratories market, 2012 - 2022 (USD Million) FIG. 20 Molecular diagnostics revenue share by application, 2013 & 2022 FIG. 21 Molecular diagnostics based infectious disease market, 2012 - 2022 (USD Million) FIG. 22 MRSAinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 23 Clostridium difficileinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 24 Vancomycin resistant enterococciinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 25 Carbapenem resistant bacteria testinginfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 26 Fluinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 27 Respiratory syncytial virus (RSV)infectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 28 Candidainfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 29 Tuberculosis and drug resistant TBinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 30 Meningitisinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 31 Gastro intestinal panel testinginfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 32 Chlamydiainfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 33 Gonorrheainfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 34 HIVinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 35 Hepatitis Cinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 36 Hepatitis Binfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 37 Otherinfectious diseasebased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 38 Molecular diagnostics based genetic testing market, 2012 - 2022 (USD Million) FIG. 39 Newborn screening genetic testingbased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 40 Predictive and presymptomaticgenetic testingbased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 41 Othergenetic testingbased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 42 Molecular diagnostics based oncology market, 2012 - 2022 (USD Million) FIG. 43 Breast cancer based molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 44 Prostate cancer based molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 45 Colorectal cancerbased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 46 Other oncology applicationbased molecular diagnostics market, 2012 - 2022 (USD Million) FIG. 47 Molecular diagnostics based pharmacogenomics market, 2012 - 2022 (USD Million) FIG. 48 Molecular diagnostics based cardiovascular diseases market, 2012 - 2022 (USD Million) FIG. 49 Molecular diagnostics based food safety diseases market, 2012 - 2022 (USD Million) FIG. 50 Molecular diagnostics based microbiology diseases market, 2012 - 2022 (USD Million) FIG. 51 Molecular diagnostics in other application segments market revenue, 2012 - 2022 (USD Million) FIG. 52 Molecular Diagnostics revenue share by technology, 2014 & 2022 FIG. 53 Molecular Diagnostics PCR Market, 2012 - 2022 (USD Million) FIG. 54 Multiplex PCR Based Molecular Diagnostics Market, 2012 - 2022 (USD Million) FIG. 55 Other PCR Based Molecular Diagnostics Market, 2012 - 2022 (USD Million) FIG. 56 Molecular Diagnostic TMA Market, 2012 - 2022 (USD Million) FIG. 57 Molecular Diagnostics In-situ Hybridization Market, 2012 - 2022 (USD Million) FIG. 58 Molecular Diagnostic Sequencing Market, 2012 - 2022 (USD Million) FIG. 59 Molecular Diagnostics Chips and Microarrays Market, 2012 - 2022 (USD Million) FIG. 60 Molecular Diagnostics Mass Spectrometry Market, 2012 - 2022 (USD Million) FIG. 61 Molecular Diagnostic Other Technology Segments Market, 2012 - 2022 (USD Million) FIG. 62 Molecular Diagnostics revenue share by region, 2014 & 2022 FIG. 63 North America Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 64 U.S. Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 65 Canada Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 66 Europe Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 67 UK Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 68 Germany Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 69 France Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 70 Italy Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 71 Colombia Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 72 Asia Pacific Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 73 Japan Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 74 China Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 75 India Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 76 Australia Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 77 New Zealand Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 78 Latin America Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 79 Brazil Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 80 Brazil Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 81 Brazil Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 82 MEA Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 83 South Africa Molecular Diagnostic Market, 2012 - 2022 (USD Million) FIG. 84 Saudi Arabia Molecular Diagnostic Market, 2012 - 2022 (USD Million)

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

To learn more about this report, request a free sample copy

Choose License Type
Single User - US $4950
Multi User - US $7950
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify